Methyl dopa acts on which of the following receptor?

**Core Concept**
Methyl dopa is a centrally acting antihypertensive agent that functions by stimulating the release of norepinephrine in the central nervous system, leading to decreased sympathetic tone and subsequent vasodilation.

**Why the Correct Answer is Right**
Methyl dopa acts on the **imidazoline receptor** in the central nervous system, specifically in the rostral ventrolateral medulla (RVLM). This receptor stimulation leads to the release of norepinephrine, which in turn activates the alpha-2 adrenergic receptors, resulting in decreased sympathetic outflow to the peripheral vasculature. This decrease in sympathetic tone leads to vasodilation and a subsequent decrease in blood pressure.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as methyl dopa does not act on the alpha-1 adrenergic receptors, which are primarily involved in peripheral vasoconstriction.

**Option B:** This option is incorrect as methyl dopa does not act on the beta-2 adrenergic receptors, which are primarily involved in bronchodilation and vasodilation in skeletal muscle.

**Option C:** This option is incorrect as methyl dopa does not act on the dopamine receptors, which are primarily involved in the regulation of movement and reward.

**Clinical Pearl / High-Yield Fact**
Methyl dopa is a classic example of a centrally acting antihypertensive agent that works by stimulating the release of norepinephrine in the central nervous system, leading to decreased sympathetic tone and subsequent vasodilation. This mechanism of action is unique among antihypertensive agents and is an important concept to remember for medical students.

**Correct Answer:** C.